Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Frontiers in Endocrinology|January 1, 2026
Case Report: Generalized lipodystrophy following immune-checkpoint inhibitor therapyAndrew-Hyun Lee, Rina Hui, Jenny E Gunton
Asia-Pacific Journal of Clinical Oncology|November 2, 2020
Optimizing care for younger women with hormone receptor-positive, HER2-negative metastatic breast cancerRichard de Boer, Rina Hui, Elgene Lim, et al.
Endocrinology, Diabetes & Metabolism Case Reports|August 22, 2020
Occult metastatic thyroid cancer diagnosed during breast cancer axillary sentinel node biopsyPratima Herle, Steven Boyages, Rina Hui, et al.
Asia-Pacific Journal of Clinical Oncology|January 28, 2021
CDK4/6 inhibitor plus endocrine therapy for hormone receptor-positive, HER2-negative metastatic breast cancer: The new standard of careRina Hui, Richard de Boer, Elgene Lim, et al.
Heart, Lung & Circulation|October 8, 2023
Alterations in Left Atrial Strain in Breast Cancer Patients Immediately Post Anthracycline ExposurePeter Emerson, Luke Stefani, Anita Boyd, et al.
Breast Cancer Research and Treatment|May 21, 2003
Cyclin D1, EMS1 and 11q13 amplification in breast cancerChristopher J Ormandy, Elizabeth A Musgrove, Rina Hui, et al.
Echocardiography (Mount Kisco, N.Y.)|March 3, 2012
Trastuzumab-induced cardiotoxicity: the role of two-dimensional myocardial strain imaging in diagnosis and managementPaul Stoodley, David Tanous, David Richards, et al.
Journal for Immunotherapy of Cancer|June 4, 2021
Neoadjuvant immunotherapy for non-small cell lung cancer: right drugs, right patient, right time?Elizabeth Ahern, Ben J Solomon, Rina Hui, et al.
Thoracic Cancer|January 10, 2023
Use of durvalumab in stage III non-small-cell lung cancer based on eligibility for the PACIFIC studyEmma Boys, Bo Gao, Rina Hui, et al.
Pageof 9